Our MHRA Phase I Accreditation and GCP inspection in May 2024 resulted in no critical or major findings, demonstrating that Simbec-Orion continues to be the leading, fully-comprehensive, clinical pharmacology and laboratory facility within the UK. Well done to everyone on the team!
An MHRA phase I accreditation demands the highest quality clinical trials, delivered by experienced and capable teams, with participant health and safety prioritised above all else. Read about why this should be your top consideration for your upcoming volunteer or patient trial in our blog series on the topic.